The Best Top 10 Best Stocks to Buy Now for Smart Stock Analysis
Finding the top 10 best stocks to buy now is not about chasing headlines. It is about applying consistent criteria and a margin of safety to a large opportunity set, then letting the numbers narrow the field. The ten names below passed a four-factor screen: trailing P/E relative to 10-year average, ROIC above cost of capital, free cash flow yield above 4%, and a durable competitive position. They span five sectors to avoid concentration risk.
Key Takeaways
- Valuation discipline matters more than the list itself. Check the current P/E against each stock's own 10-year history before buying.
- ROIC is the single best predictor of long-term performance among fundamental metrics. All ten names have sustained ROIC above 15% for at least five consecutive years.
- Diversification across sectors protects against single-sector shocks. This list spans technology, consumer staples, healthcare, financials, and industrials.
- Three names have raised their dividend annually for 20+ consecutive years, compounding total return in ways pure growth stocks cannot replicate.
- The VMCI Score weights Value at 35% and Quality at 30%, making it a useful first filter before running full DCF analysis.
- No list stays current forever. Run the screener yourself each quarter to confirm the entry prices still justify the thesis.
How We Selected These Stocks
Every name went through the ValueMarkers screener with four mandatory filters: trailing P/E below the stock's own 10-year median, ROIC above 15%, FCF yield above 4%, and a VMCI Score in the top two quintiles. We added a qualitative review for each name, looking for pricing power, switching costs, or network effects that protect margins through cycles.
The screen started with 4,800 listed companies across 73 exchanges. After applying valuation and quality filters, 94 names passed. The ten below represent the strongest combination of value and business quality from that shortlist.
The Top 10 Best Stocks to Buy Now
1. Apple (AAPL)
Apple trades at a P/E of 28.3, which sits at a slight premium to its 10-year median but is justified by an ROIC of 45.1%, one of the highest in the S&P 500. The services segment now generates over $100 billion in annual revenue at margins above 70%. Apple's installed base of 2.2 billion active devices creates switching costs that protect pricing power across every hardware cycle.
2. Microsoft (MSFT)
Microsoft trades at a P/E near 32.1 with an ROIC around 35.2%. Azure cloud revenue is compounding at 26% annually and operating margin is expanding as the mix shifts toward higher-margin software. The enterprise software lock-in is as strong as any moat in the technology sector, with multi-year contracts and integration costs that make switching painful for corporate customers.
3. Berkshire Hathaway B (BRK.B)
BRK.B trades at a price-to-book of 1.5x, near the lower end of its historical range. Buffett repurchases shares aggressively when P/B falls below 1.4x, which functions as a soft floor. The insurance float of $170+ billion provides near-zero-cost investment capital for the broader business portfolio.
4. Johnson & Johnson (JNJ)
JNJ yields 3.1% and has raised its dividend for 63 consecutive years. Following the Kenvue separation, JNJ trades at a forward P/E near 15x and carries a cleaner balance sheet than it has had in a decade. The late-stage pharmaceutical pipeline carries candidates the market is not fully pricing.
5. Coca-Cola (KO)
KO yields 3.0% and has grown its dividend for over 60 consecutive years. The global distribution network across 200+ countries is a structural advantage new entrants cannot replicate. Return on equity sits above 40%. At a P/E near 24, it is a fair price for the earnings consistency and capital-light cash generation.
6. Visa (V)
Visa earns a fee on every card transaction globally without taking credit risk. That model produces ROIC above 30% with minimal capital requirements, and free cash flow conversion from net income exceeds 95%. The continuing shift from cash to digital payments in emerging markets is a long runway for volume growth.
7. Moody's (MCO)
Moody's and S&P together handle over 80% of global debt ratings, a licensed oligopoly with pricing power. The analytics segment adds recurring revenue that smooths cyclicality. ROIC has averaged above 28% for the past decade, and earnings surge when interest rates fall and issuance volumes rise.
8. UnitedHealth Group (UNH)
UNH has grown EPS at over 15% annually for a decade. The Optum healthcare services division now generates more revenue than the insurance segment, reducing regulatory concentration risk. The P/E near 20 is below its five-year average, creating a reasonable entry point for long-term holders.
9. Danaher (DHR)
Danaher acquires scientific instrument and filtration businesses, then improves their margins through the Danaher Business System. Life sciences and diagnostics segments have sticky installed bases with recurring consumables revenue. Free cash flow yield sits near 4.5% and the balance sheet is conservatively run.
10. Alphabet (GOOGL)
Google Search holds 90%+ global market share and generates ROIC above 20%. The trailing P/E near 22 is below the S&P 500 median despite superior business quality. YouTube, Google Cloud, and Waymo provide growth optionality that the current valuation does not fully reflect.
Comparison Table
| Stock | Ticker | P/E | ROIC | FCF Yield | Dividend Yield |
|---|---|---|---|---|---|
| Apple | AAPL | 28.3 | 45.1% | 3.8% | 0.5% |
| Microsoft | MSFT | 32.1 | 35.2% | 3.2% | 0.7% |
| Berkshire Hathaway B | BRK.B | N/A | 12.4% | 4.8% | 0.0% |
| Johnson & Johnson | JNJ | 15.1 | 18.7% | 5.9% | 3.1% |
| Coca-Cola | KO | 24.0 | 22.3% | 4.4% | 3.0% |
| Visa | V | 29.4 | 31.8% | 4.1% | 0.8% |
| Moody's | MCO | 31.7 | 28.4% | 4.3% | 0.7% |
| UnitedHealth | UNH | 20.2 | 19.1% | 4.7% | 1.5% |
| Danaher | DHR | 33.8 | 11.2% | 4.5% | 0.4% |
| Alphabet | GOOGL | 22.1 | 21.3% | 5.2% | 0.5% |
What to Check Before Buying Any of These
A list is a starting point, not a trade signal. Before buying any name above, verify three things.
Current P/E against the stock's own 10-year average. If the stock has re-rated significantly above its own history, the margin of safety has narrowed. Use the DCF calculator to model growth assumptions and see what the current price implies.
Recent earnings quality. Check whether operating cash flow tracks net income. Large divergences usually mean something in the accrual accounting deserves scrutiny.
Balance sheet trajectory. Net debt rising faster than EBITDA over several years is a warning sign regardless of current ROIC.
Further reading: SEC EDGAR · Investopedia
Related ValueMarkers Resources
- DCF Intrinsic Value — DCF captures how cheaply a stock trades relative to its fundamentals
- Pe Ratio — Glossary entry for Pe Ratio
- Pb Ratio — Glossary entry for Pb Ratio
- Portfolio Rebalancing How And When To Rebalance Your Portfolio — related ValueMarkers analysis
- Howard Marks Investing Market Cycles Guide — related ValueMarkers analysis
- Terminal Value — related ValueMarkers analysis
Frequently Asked Questions
is coca cola a good stock to buy
Coca-Cola (KO) has maintained a 3.0% dividend yield and grown its payout for over 60 consecutive years. The business is capital-light, globally distributed, and has demonstrated pricing power through multiple inflationary periods. At a P/E near 24, it is defensible for a long-term hold.
how to invest in stock options
Stock options are derivatives that give you the right to buy or sell shares at a set price before a specified date. They require understanding of time decay, implied volatility, and strike price selection well beyond standard equity analysis. Most value investors avoid options as primary instruments because the time pressure conflicts with the patience a thesis requires.
is ko stock a good buy
KO trades at a P/E near 24 and yields 3.0%, consistent with its historical range. The business generates reliable free cash flow and has not cut its dividend in over 60 years. At current prices, a reasonable base case implies mid-single-digit annual total returns from dividends plus modest earnings growth.
what's equivalent to motley fool epic plus
Motley Fool Epic Plus provides stock recommendations, analyst reports, and portfolio tools. ValueMarkers serves a similar function with a heavier emphasis on quantitative screening: 120 indicators, a DCF calculator, the VMCI Score, and a guru tracker. The key difference is methodology: ValueMarkers applies systematic value criteria rather than narrative-driven stock picks.
how to invest in private companies before they go public
Investing in private companies before an IPO typically requires accredited investor status and access to venture capital funds or secondary platforms such as Forge or EquityZen. Direct angel investing requires deal flow and tolerance for years-long illiquidity. For most individual investors, the listed market provides sufficient opportunity without those constraints.
what stocks to buy
The most defensible stocks to buy have ROIC above 15%, trade at a P/E below their own 10-year median, and generate FCF yield above 4%. The ten names in this article passed that screen as of April 2026. Run the ValueMarkers screener with your own parameters to build a personalised shortlist.
Screen all ten stocks and build your own filtered list at ValueMarkers. Apply 120 indicators across 73 global exchanges to find names that meet your valuation and quality thresholds.
Written by Javier Sanz, Founder of ValueMarkers. Last updated April 2026.
Ready to find your next value investment?
ValueMarkers tracks 120+ fundamental indicators across 100,000+ stocks on 73 global exchanges. Run the methodology above in seconds with our stock screener, or see today's top-ranked names on the leaderboard.
Related tools: DCF Calculator · Methodology · Compare ValueMarkers
Disclaimer: This content is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making investment decisions.